Logo image of CHX

CHAMPIONX CORP (CHX) Stock Fundamental Analysis

NASDAQ:CHX - Nasdaq - US15872M1045 - Common Stock - Currency: USD

26.61  -0.77 (-2.81%)

Fundamental Rating

6

Taking everything into account, CHX scores 6 out of 10 in our fundamental rating. CHX was compared to 62 industry peers in the Energy Equipment & Services industry. CHX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CHX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CHX had positive earnings in the past year.
CHX had a positive operating cash flow in the past year.
Of the past 5 years CHX 4 years were profitable.
In the past 5 years CHX always reported a positive cash flow from operatings.
CHX Yearly Net Income VS EBIT VS OCF VS FCFCHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

CHX has a Return On Assets of 8.37%. This is in the better half of the industry: CHX outperforms 79.03% of its industry peers.
Looking at the Return On Equity, with a value of 15.29%, CHX is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
The Return On Invested Capital of CHX (14.15%) is better than 88.71% of its industry peers.
CHX had an Average Return On Invested Capital over the past 3 years of 13.65%. This is significantly above the industry average of 8.42%.
The last Return On Invested Capital (14.15%) for CHX is above the 3 year average (13.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROIC 14.15%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
CHX Yearly ROA, ROE, ROICCHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

CHX's Profit Margin of 8.20% is fine compared to the rest of the industry. CHX outperforms 66.13% of its industry peers.
In the last couple of years the Profit Margin of CHX has grown nicely.
CHX's Operating Margin of 14.41% is fine compared to the rest of the industry. CHX outperforms 72.58% of its industry peers.
CHX's Operating Margin has improved in the last couple of years.
CHX has a better Gross Margin (33.16%) than 62.90% of its industry peers.
In the last couple of years the Gross Margin of CHX has remained more or less at the same level.
Industry RankSector Rank
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
CHX Yearly Profit, Operating, Gross MarginsCHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHX is still creating some value.
CHX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CHX has been increased compared to 5 years ago.
CHX has a better debt/assets ratio than last year.
CHX Yearly Shares OutstandingCHX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CHX Yearly Total Debt VS Total AssetsCHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CHX has an Altman-Z score of 3.76. This indicates that CHX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CHX (3.76) is better than 85.48% of its industry peers.
CHX has a debt to FCF ratio of 1.74. This is a very positive value and a sign of high solvency as it would only need 1.74 years to pay back of all of its debts.
The Debt to FCF ratio of CHX (1.74) is better than 80.65% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that CHX is not too dependend on debt financing.
The Debt to Equity ratio of CHX (0.31) is better than 61.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Altman-Z 3.76
ROIC/WACC1.51
WACC9.34%
CHX Yearly LT Debt VS Equity VS FCFCHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CHX has a Current Ratio of 2.25. This indicates that CHX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.25, CHX is in the better half of the industry, outperforming 69.35% of the companies in the same industry.
A Quick Ratio of 1.62 indicates that CHX should not have too much problems paying its short term obligations.
CHX has a Quick ratio of 1.62. This is in the better half of the industry: CHX outperforms 61.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.62
CHX Yearly Current Assets VS Current LiabilitesCHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CHX have decreased by -1.63% in the last year.
The Earnings Per Share has been growing by 11.09% on average over the past years. This is quite good.
Looking at the last year, CHX shows a decrease in Revenue. The Revenue has decreased by -4.17% in the last year.
CHX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.29% yearly.
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%

3.2 Future

The Earnings Per Share is expected to grow by 6.80% on average over the next years.
The Revenue is expected to grow by 2.82% on average over the next years.
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHX Yearly Revenue VS EstimatesCHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
CHX Yearly EPS VS EstimatesCHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.70 indicates a correct valuation of CHX.
The rest of the industry has a similar Price/Earnings ratio as CHX.
The average S&P500 Price/Earnings ratio is at 27.41. CHX is valued slightly cheaper when compared to this.
CHX is valuated correctly with a Price/Forward Earnings ratio of 13.65.
CHX's Price/Forward Earnings is on the same level as the industry average.
CHX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 14.7
Fwd PE 13.65
CHX Price Earnings VS Forward Price EarningsCHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHX is valued a bit more expensive than the industry average as 64.52% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 14.88
EV/EBITDA 6.97
CHX Per share dataCHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CHX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of CHX may justify a higher PE ratio.
PEG (NY)2.31
PEG (5Y)1.33
EPS Next 2Y3.8%
EPS Next 3Y5.08%

3

5. Dividend

5.1 Amount

CHX has a Yearly Dividend Yield of 1.41%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.52, CHX pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.41, CHX pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.41%

5.2 History

The dividend of CHX decreases each year by -47.78%.
CHX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)-47.78%
Div Incr Years2
Div Non Decr Years2
CHX Yearly Dividends per shareCHX Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

CHX pays out 24.70% of its income as dividend. This is a sustainable payout ratio.
DP24.7%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
CHX Yearly Income VS Free CF VS DividendCHX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
CHX Dividend Payout.CHX Dividend Payout, showing the Payout Ratio.CHX Dividend Payout.PayoutRetained Earnings

CHAMPIONX CORP

NASDAQ:CHX (7/14/2025, 3:26:09 PM)

26.61

-0.77 (-2.81%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners95.44%
Inst Owner Change0%
Ins Owners0.99%
Ins Owner Change19.68%
Market Cap5.09B
Analysts86.67
Price Target42.23 (58.7%)
Short Float %2.37%
Short Ratio1.34
Dividend
Industry RankSector Rank
Dividend Yield 1.41%
Yearly Dividend0.37
Dividend Growth(5Y)-47.78%
DP24.7%
Div Incr Years2
Div Non Decr Years2
Ex-Date07-03 2025-07-03 (0.095)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)0.36%
Max EPS beat(2)14.53%
EPS beat(4)2
Avg EPS beat(4)-2.36%
Min EPS beat(4)-19.69%
Max EPS beat(4)14.53%
EPS beat(8)4
Avg EPS beat(8)0.56%
EPS beat(12)8
Avg EPS beat(12)1.75%
EPS beat(16)11
Avg EPS beat(16)1.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-1.16%
Revenue beat(4)0
Avg Revenue beat(4)-4.29%
Min Revenue beat(4)-7.8%
Max Revenue beat(4)-1.16%
Revenue beat(8)0
Avg Revenue beat(8)-3.77%
Revenue beat(12)2
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)-3.72%
EPS NQ rev (1m)-2.98%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)-6.47%
EPS NY rev (3m)-10.47%
Revenue NQ rev (1m)-1.62%
Revenue NQ rev (3m)-4.6%
Revenue NY rev (1m)-2.72%
Revenue NY rev (3m)-7.4%
Valuation
Industry RankSector Rank
PE 14.7
Fwd PE 13.65
P/S 1.42
P/FCF 14.88
P/OCF 10.55
P/B 2.66
P/tB 4.85
EV/EBITDA 6.97
EPS(TTM)1.81
EY6.8%
EPS(NY)1.95
Fwd EY7.33%
FCF(TTM)1.79
FCFY6.72%
OCF(TTM)2.52
OCFY9.48%
SpS18.68
BVpS10.01
TBVpS5.48
PEG (NY)2.31
PEG (5Y)1.33
Profitability
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROCE 18.98%
ROIC 14.15%
ROICexc 17.55%
ROICexgc 29.07%
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
FCFM 9.57%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
ROICexc(3y)15.86%
ROICexc(5y)10.93%
ROICexgc(3y)28.04%
ROICexgc(5y)19.36%
ROCE(3y)18.31%
ROCE(5y)12.72%
ROICexcg growth 3Y47.18%
ROICexcg growth 5Y16.9%
ROICexc growth 3Y46.83%
ROICexc growth 5Y30.42%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Debt/EBITDA 0.78
Cap/Depr 57.1%
Cap/Sales 3.93%
Interest Coverage 250
Cash Conversion 63.4%
Profit Quality 116.78%
Current Ratio 2.25
Quick Ratio 1.62
Altman-Z 3.76
F-Score6
WACC9.34%
ROIC/WACC1.51
Cap/Depr(3y)53.43%
Cap/Depr(5y)43.4%
Cap/Sales(3y)3.46%
Cap/Sales(5y)3.1%
Profit Quality(3y)155.68%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%
EBIT growth 1Y0.17%
EBIT growth 3Y40.57%
EBIT growth 5Y37.22%
EBIT Next Year52.58%
EBIT Next 3Y14.47%
EBIT Next 5Y9.48%
FCF growth 1Y-23.96%
FCF growth 3Y22.54%
FCF growth 5Y31.03%
OCF growth 1Y-12.01%
OCF growth 3Y21.57%
OCF growth 5Y30.48%